Neuroprotective effect of NPY on kainate neuroteoxicity in the hippocampus

Polish Journal of Pharmacology

Volumn 55, Issue 6, 2003, Pages 979-986

  Śmiałowska, Maria ^a   Wierońska, Joanna M ^a   Szewczyk, Bernadeta ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Hippocampus; Kainic acid; Neuroprotection; NPY

Indexed keywords

KAINIC ACID; NEUROPEPTIDE Y;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; BRAIN REGION; CANNULATION; CONTROLLED STUDY; DENTATE GYRUS; DISEASE MODEL; DOSE RESPONSE; GRANULAR CELL; HIPPOCAMPUS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTERNEURON; MALE; MEDICAL ASSESSMENT; MICROINJECTION; MOSSY FIBER; NERVE CELL DEGENERATION; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; PYRAMIDAL NERVE CELL; RAT; TIME;

ANIMALS; EXCITATORY AMINO ACID AGONISTS; HIPPOCAMPUS; KAINIC ACID; MALE; MICROINJECTIONS; NEUROPEPTIDE Y; NEUROPROTECTIVE AGENTS; PYRAMIDAL CELLS; RATS; RATS, WISTAR;

EID: 18544401319     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Abel P.W., Han C.: Effects of neuropeptide Y on contraction, relaxation and membrane potential of rabbit cerebral arteries. J. Cardiovasc. Pharmacol., 1989, 13, 52-63.
2. Bellmann R., Widmann R., Olenik C., Meyer D.K., Maas D., Marksteiner J., Sperk G.: Enhanced rate of expression and biosynthesis of neuropeptide Y after kainic acid-induced seizures. J. Neurochem., 1991, 56, 525-530.
3. Ben-Ari Y., Cossart R.: Kainate, a double agent that generates seizures: two decades of progress. Trends Neurosci., 2000, 23, 580-587.
4. Bijak M., Śmiałowska M.: Effects of neuropeptide Y evoked potentials in the CA1 region and the dentate gyrus of the rat hippocampal slice. Pol. J. Pharmacol., 1995, 47, 333-338.
5. Chen S.-H., Cheung R.T.F.: Peripheral and central administration of neuropeptide Y in a rat middle cerebral artery occlusion stroke model reduces cerebral blood flow and increases infarct volume. Brain Res., 2002, 927, 138-143.
6. Cheung R.T.F., Cechetto D.F.: Neuropeptide Y - Y1 receptor antisense oligodeoxynucleotide increases the infarct volume after middle cerebral artery occlusion in rats. Neuroscience, 2000, 98, 771-777.
7. Colmers W.F.: Modulation of synaptic transmission in hippocampus by neuropeptide Y: presynaptic actions. Ann. NY. Acad. Sci., 1990, 611, 206-218.
8. Colmers W.F., Lukowiak K., Pittman Q.J.: Presynaptic action of neuropeptide Y in area CA1 of the rat hippocampal slice. J. Physiol., 1987, 383, 285-299.
9. El Bahh B., Auvergne R., Lere C., Brana C., Le Gal La Salle G., Rougier A.: Decreased epileptic susceptibility correlates with neuropeptide Y overexpression in a model of tolerance to excitotoxicity. Brain Res., 2001, 894, 209-217.
10. Ferkany J.W., Coyle J.T.: Kainic acid selectively stimulates the release of endogenous excitatory acidic amino acids. J. Pharmacol. Exp. Ther., 1983, 225, 399-406.
11. Gray T.S., Morley J.E.: Neuropeptide Y: anatomical distribution and possible function in mammalian nervous system. Life Sci., 1986, 38, 389-401.
12. Greber S., Schwarzer C., Sperk G.: Neuropeptide Y inhibits potassium-stimulated glutamate release through Y2 receptors in rat hippocampal slices in vitro. Brit. J. Pharmacol., 1994, 113, 737-740.
13. Gruber B., Greber S., Rupp E., Sperk G.: Differential NPY mRNA expression in granule cells and interneurons of the rat dentate gyrus after kainic acid injection. Hippocampus, 1994, 4, 474-482.
14. Hsu S.M., Raine L., Fanger H.: Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabelled antibody (PAP) procedures. J. Histochem. Cytochem., 1981, 29, 577-580.
15. Klapstein G.J., Colmers W. F.: On the sites of presynaptic inhibition by neuropeptide Y in rat hippocampus in vitro. Hippocampus, 1993, 3, 103-112.
16. Klapstein G.J., Colmers W.F.: Neuropeptide Y suppresses epileptiform activity in rat hippocampus in vitro. J. Neurophysiol., 1997, 78, 1651-1661.
17. Köhler Ch., Eriksson L., Davies S., Chan-Palay V.: Neuropeptide Y innervation of the hippocampal region in the rat and monkey brain. J. Comp. Neurol., 1986, 244, 384-400.
18. Lere C., El Bahh B., Le Gal La Salle G., Rougier A.: A model of "epileptic tolerance" for investigating neuroprotection, epileptic susceptibility and gene expression-related plastic changes. Brain Res. Protocols, 2002, 9, 49-56.
19. Lurton D., Coussemacq M., Barrow P., Sundstrom L.E., Rougier A.: Widespread ectopic neuropeptide-Y immunoreactivity in contralateral mossy fibres after a unilateral intrahippocampal kainic acid injection in the rat. Neurosci. Lett., 1996, 213, 181-184.
20. Makiura Y., Suzuki F., Chevalier E., Ontiente B.: Excitatory granule cells of the dentate gyrus exhibit a double neurochemical content after intrahippocampal administration of kainate in adult mice. Exp. Neurol., 1999, 159, 73-83.
21. Paxinos G., Watson C.: The Rat Brain in Stereotaxic Coordinates. Academic Press, San Diego, CA, 1986.
22. Schwarcz R., Zaczek R., Coyle J.T.: Microinjection of kainic acid into the rat hippocampus. Eur. J. Pharmacol., 1978, 50, 209-220.
23. Schwarzer C., Sperk G., Samanin R., Rizzi M., Gariboldi M., Vezzani A.: Neuropeptides-immunoreactivity and their mRNA expression in kindling: functional implications for limbic epileptogenesis. Brain Res. Rev., 1996, 22, 27-50.
24. Sperk G., Marksteiner J., Gruber B., Bellman R., Mahata M., Ortler M.: Functional changes in neuropeptide Y- and somatostatin-containing neurons induced by limbic seizures in the rat. Neuroscience, 1992, 50, 831-846.
25. Śmiałowska M.: Neuropeptide Y immunoreactivity in the locus coeruleus of the rat brain. Neuroscience, 1998, 25, 123-131.
26. Śmiałowska M., Bijak M., Sopala M., Tokarski K.: Inhibitory effect of NPY on the picrotoxin-induced activity in the hippocampus: a behavioural and electrophysiological study. Neuropeptides, 1996, 30, 7-12.
27. Śmiałowski A.: Different sensitivity of hippocampal neurons to kainic acid in the rabbit. Neuroscience, 1980, 5, 1475-1478.
28. Tuor U.I., Kelly P.A., Edvinsson L., McCulloch J.: Neuropeptide Y and the cerebral circulation. J. Cerebr. Blood Flow Metabol., 1990, 10, 591-601.